
About us
Liminal BioSciences is a development-stage biopharmaceutical company focused on developing distinctive novel small molecule therapeutics for metabolic, fibrotic and inflammatory diseases using our drug discovery platform and data-driven approach.

Product pipeline
Our expertise in small molecules has enabled a strong pipeline with potential first/best-in-class drug candidates.

Investors
Find out more on how Liminal BioSciences (NASDAQ: LMNL) is developing a pipeline of novel small molecule therapeutics.